Who founded Opticyte?

Opticyte was founded by Lori Arakaki in 2016.

Who are Opticyte's investors?

Opticyte's investors include Swan Venture Fund.

How much funding has Opticyte raised?

Opticyte has disclosed $72.3K raised across 1 round.

Where is Opticyte headquartered?

Opticyte is headquartered in Seattle, US.

Opticyte

Seattle, US · Founded 2016 · 1 known investors

opticyte.com ↗

Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.

BiotechHealthtechMedical Devices

Founders & leadership

Opticyte was founded in 2016 by Lori Arakaki.

Lori ArakakiinFounder

Robert MastersonNamed on SEC filing

Kenneth SchenkmanNamed on SEC filing

Lorilee ArakakiNamed on SEC filing

Investors · 1

Swan Venture FundSeattle · $200K – $1.2M

Reported raises · per SEC filings

Form D private placements

$72.3K disclosed across 1 round · 2017

▶$72.3KraisedOct 2017 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert MastersonExecutive Officer, Director, Promoter
Kenneth SchenkmanExecutive Officer, Director, Promoter
Lorilee ArakakiExecutive Officer, Director, Promoter

Offering amount: $2.3M
Amount sold: $72.3K
First sale: Sep 2017
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Triple Ring Technologies3 shared keywords

Companies competing with Opticyte for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Opticyte do?: Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
Who founded Opticyte?: Opticyte was founded by Lori Arakaki in 2016.
Who are Opticyte's investors?: Opticyte's investors include Swan Venture Fund.
How much funding has Opticyte raised?: Opticyte has disclosed $72.3K raised across 1 round.
Where is Opticyte headquartered?: Opticyte is headquartered in Seattle, US.